These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29236669)

  • 41. Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms.
    Mudo G; Belluardo N; Fuxe K
    J Neural Transm (Vienna); 2007 Jan; 114(1):135-47. PubMed ID: 16906354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The α7 nAChR selective agonists as drug candidates for Alzheimer's disease.
    Fan H; Gu R; Wei D
    Adv Exp Med Biol; 2015; 827():353-65. PubMed ID: 25387975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nicotine facilitates nicotinic acetylcholine receptor targeting to mitochondria but makes them less susceptible to selective ligands.
    Uspenska K; Lykhmus O; Gergalova G; Chernyshov V; Arias HR; Komisarenko S; Skok M
    Neurosci Lett; 2017 Aug; 656():43-50. PubMed ID: 28700952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective deletion of the alpha5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse.
    Fischer H; Orr-Urtreger A; Role LW; Huck S
    J Physiol; 2005 Feb; 563(Pt 1):119-37. PubMed ID: 15611037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
    Newhouse PA; Potter A; Levin ED
    Drugs Aging; 1997 Sep; 11(3):206-28. PubMed ID: 9303280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression patterns of nicotinic subunits α2, α7, α8, and β1 affect the kinetics and pharmacology of ACh-induced currents in adult bee olfactory neuropiles.
    Dupuis JP; Gauthier M; Raymond-Delpech V
    J Neurophysiol; 2011 Oct; 106(4):1604-13. PubMed ID: 21734106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors.
    Anderson SM; Brunzell DH
    Br J Pharmacol; 2015 Jun; 172(11):2864-77. PubMed ID: 25625469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation.
    Scholze P; Orr-Urtreger A; Changeux JP; McIntosh JM; Huck S
    Br J Pharmacol; 2007 Jun; 151(3):414-22. PubMed ID: 17401441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders.
    Mihailescu S; Drucker-Colín R
    Arch Med Res; 2000; 31(2):131-44. PubMed ID: 10880717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nicotinic acetylcholine receptors in neurological and psychiatric diseases.
    Terry AV; Jones K; Bertrand D
    Pharmacol Res; 2023 May; 191():106764. PubMed ID: 37044234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuronal nicotinic receptors in the human brain.
    Paterson D; Nordberg A
    Prog Neurobiol; 2000 May; 61(1):75-111. PubMed ID: 10759066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optogenetic studies of nicotinic contributions to cholinergic signaling in the central nervous system.
    Jiang L; López-Hernández GY; Lederman J; Talmage DA; Role LW
    Rev Neurosci; 2014; 25(6):755-71. PubMed ID: 25051276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting neuronal nicotinic receptors: a path to new therapies.
    Bencherif M; Schmitt JD
    Curr Drug Targets CNS Neurol Disord; 2002 Aug; 1(4):349-57. PubMed ID: 12769609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity.
    Sher E; Chen Y; Sharples TJ; Broad LM; Benedetti G; Zwart R; McPhie GI; Pearson KH; Baldwinson T; De Filippi G
    Curr Top Med Chem; 2004; 4(3):283-97. PubMed ID: 14754448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overview of nicotinic receptors and their roles in the central nervous system.
    Dani JA
    Biol Psychiatry; 2001 Feb; 49(3):166-74. PubMed ID: 11230867
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.